IBDEI0BF ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11428,1,3,0)
 ;;=3^Exophoria
 ;;^UTILITY(U,$J,358.3,11428,1,4,0)
 ;;=4^H50.52
 ;;^UTILITY(U,$J,358.3,11428,2)
 ;;=^265436
 ;;^UTILITY(U,$J,358.3,11429,0)
 ;;=H51.11^^53^611^4
 ;;^UTILITY(U,$J,358.3,11429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11429,1,3,0)
 ;;=3^Convergence Insufficiency
 ;;^UTILITY(U,$J,358.3,11429,1,4,0)
 ;;=4^H51.11
 ;;^UTILITY(U,$J,358.3,11429,2)
 ;;=^5006251
 ;;^UTILITY(U,$J,358.3,11430,0)
 ;;=H51.12^^53^611^3
 ;;^UTILITY(U,$J,358.3,11430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11430,1,3,0)
 ;;=3^Convergence Excess
 ;;^UTILITY(U,$J,358.3,11430,1,4,0)
 ;;=4^H51.12
 ;;^UTILITY(U,$J,358.3,11430,2)
 ;;=^5006252
 ;;^UTILITY(U,$J,358.3,11431,0)
 ;;=H53.033^^53^611^11
 ;;^UTILITY(U,$J,358.3,11431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11431,1,3,0)
 ;;=3^Strabismic Amblyopia,Bilateral
 ;;^UTILITY(U,$J,358.3,11431,1,4,0)
 ;;=4^H53.033
 ;;^UTILITY(U,$J,358.3,11431,2)
 ;;=^5006305
 ;;^UTILITY(U,$J,358.3,11432,0)
 ;;=H53.032^^53^611^12
 ;;^UTILITY(U,$J,358.3,11432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11432,1,3,0)
 ;;=3^Strabismic Amblyopia,Left Eye
 ;;^UTILITY(U,$J,358.3,11432,1,4,0)
 ;;=4^H53.032
 ;;^UTILITY(U,$J,358.3,11432,2)
 ;;=^5006304
 ;;^UTILITY(U,$J,358.3,11433,0)
 ;;=H53.031^^53^611^13
 ;;^UTILITY(U,$J,358.3,11433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11433,1,3,0)
 ;;=3^Strabismic Amblyopia,Right Eye
 ;;^UTILITY(U,$J,358.3,11433,1,4,0)
 ;;=4^H53.031
 ;;^UTILITY(U,$J,358.3,11433,2)
 ;;=^5006303
 ;;^UTILITY(U,$J,358.3,11434,0)
 ;;=D86.83^^53^612^20
 ;;^UTILITY(U,$J,358.3,11434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11434,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,11434,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,11434,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,11435,0)
 ;;=H53.71^^53^612^7
 ;;^UTILITY(U,$J,358.3,11435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11435,1,3,0)
 ;;=3^Glare Sensitivity
 ;;^UTILITY(U,$J,358.3,11435,1,4,0)
 ;;=4^H53.71
 ;;^UTILITY(U,$J,358.3,11435,2)
 ;;=^5006354
 ;;^UTILITY(U,$J,358.3,11436,0)
 ;;=H53.72^^53^612^9
 ;;^UTILITY(U,$J,358.3,11436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11436,1,3,0)
 ;;=3^Impaired Contrast Sensitivity
 ;;^UTILITY(U,$J,358.3,11436,1,4,0)
 ;;=4^H53.72
 ;;^UTILITY(U,$J,358.3,11436,2)
 ;;=^5006355
 ;;^UTILITY(U,$J,358.3,11437,0)
 ;;=H57.13^^53^612^14
 ;;^UTILITY(U,$J,358.3,11437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11437,1,3,0)
 ;;=3^Ocular Pain,Bilateral
 ;;^UTILITY(U,$J,358.3,11437,1,4,0)
 ;;=4^H57.13
 ;;^UTILITY(U,$J,358.3,11437,2)
 ;;=^5006384
 ;;^UTILITY(U,$J,358.3,11438,0)
 ;;=H57.11^^53^612^16
 ;;^UTILITY(U,$J,358.3,11438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11438,1,3,0)
 ;;=3^Ocular Pain,Right Eye
 ;;^UTILITY(U,$J,358.3,11438,1,4,0)
 ;;=4^H57.11
 ;;^UTILITY(U,$J,358.3,11438,2)
 ;;=^5006382
 ;;^UTILITY(U,$J,358.3,11439,0)
 ;;=H57.12^^53^612^15
 ;;^UTILITY(U,$J,358.3,11439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11439,1,3,0)
 ;;=3^Ocular Pain,Left Eye
 ;;^UTILITY(U,$J,358.3,11439,1,4,0)
 ;;=4^H57.12
 ;;^UTILITY(U,$J,358.3,11439,2)
 ;;=^5006383
 ;;^UTILITY(U,$J,358.3,11440,0)
 ;;=I10.^^53^612^8
 ;;^UTILITY(U,$J,358.3,11440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11440,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,11440,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,11440,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,11441,0)
 ;;=L71.9^^53^612^19
 ;;^UTILITY(U,$J,358.3,11441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11441,1,3,0)
 ;;=3^Rosacea,Unspec
 ;;^UTILITY(U,$J,358.3,11441,1,4,0)
 ;;=4^L71.9
 ;;^UTILITY(U,$J,358.3,11441,2)
 ;;=^5009276
 ;;^UTILITY(U,$J,358.3,11442,0)
 ;;=L71.8^^53^612^18
 ;;^UTILITY(U,$J,358.3,11442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11442,1,3,0)
 ;;=3^Rosacea NEC
 ;;^UTILITY(U,$J,358.3,11442,1,4,0)
 ;;=4^L71.8
 ;;^UTILITY(U,$J,358.3,11442,2)
 ;;=^5009275
 ;;^UTILITY(U,$J,358.3,11443,0)
 ;;=L71.1^^53^612^17
 ;;^UTILITY(U,$J,358.3,11443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11443,1,3,0)
 ;;=3^Rhinophyma
 ;;^UTILITY(U,$J,358.3,11443,1,4,0)
 ;;=4^L71.1
 ;;^UTILITY(U,$J,358.3,11443,2)
 ;;=^106083
 ;;^UTILITY(U,$J,358.3,11444,0)
 ;;=S05.31XA^^53^612^13
 ;;^UTILITY(U,$J,358.3,11444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11444,1,3,0)
 ;;=3^Ocular Laceration Right Eye w/o Prolapse/Loss of Intraoc Tissue,Init Encntr
 ;;^UTILITY(U,$J,358.3,11444,1,4,0)
 ;;=4^S05.31XA
 ;;^UTILITY(U,$J,358.3,11444,2)
 ;;=^5020606
 ;;^UTILITY(U,$J,358.3,11445,0)
 ;;=S05.32XA^^53^612^12
 ;;^UTILITY(U,$J,358.3,11445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11445,1,3,0)
 ;;=3^Ocular Laceration Left Eye w/o Prolapse/Loss of Intraoc Tissue,Init Encntr
 ;;^UTILITY(U,$J,358.3,11445,1,4,0)
 ;;=4^S05.32XA
 ;;^UTILITY(U,$J,358.3,11445,2)
 ;;=^5020609
 ;;^UTILITY(U,$J,358.3,11446,0)
 ;;=Z21.^^53^612^2
 ;;^UTILITY(U,$J,358.3,11446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11446,1,3,0)
 ;;=3^Asymptomatic HIV Infection Status
 ;;^UTILITY(U,$J,358.3,11446,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,11446,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,11447,0)
 ;;=Z83.511^^53^612^6
 ;;^UTILITY(U,$J,358.3,11447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11447,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,11447,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,11447,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,11448,0)
 ;;=Z83.518^^53^612^5
 ;;^UTILITY(U,$J,358.3,11448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11448,1,3,0)
 ;;=3^Family Hx of Eye Disorder NEC
 ;;^UTILITY(U,$J,358.3,11448,1,4,0)
 ;;=4^Z83.518
 ;;^UTILITY(U,$J,358.3,11448,2)
 ;;=^5063383
 ;;^UTILITY(U,$J,358.3,11449,0)
 ;;=Z79.899^^53^612^10
 ;;^UTILITY(U,$J,358.3,11449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11449,1,3,0)
 ;;=3^Long Term Current Drug Therapy NEC
 ;;^UTILITY(U,$J,358.3,11449,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,11449,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,11450,0)
 ;;=Z01.00^^53^612^4
 ;;^UTILITY(U,$J,358.3,11450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11450,1,3,0)
 ;;=3^Eye/Vision Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,11450,1,4,0)
 ;;=4^Z01.00
 ;;^UTILITY(U,$J,358.3,11450,2)
 ;;=^5062612
 ;;^UTILITY(U,$J,358.3,11451,0)
 ;;=Z01.01^^53^612^3
 ;;^UTILITY(U,$J,358.3,11451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11451,1,3,0)
 ;;=3^Eye/Vision Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,11451,1,4,0)
 ;;=4^Z01.01
 ;;^UTILITY(U,$J,358.3,11451,2)
 ;;=^5062613
 ;;^UTILITY(U,$J,358.3,11452,0)
 ;;=E05.90^^53^612^21
 ;;^UTILITY(U,$J,358.3,11452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11452,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec
 ;;^UTILITY(U,$J,358.3,11452,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,11452,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,11453,0)
 ;;=99201^^54^613^1
 ;;^UTILITY(U,$J,358.3,11453,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11453,1,1,0)
 ;;=1^Problem Focus
 ;;^UTILITY(U,$J,358.3,11453,1,2,0)
 ;;=2^99201
 ;;^UTILITY(U,$J,358.3,11454,0)
 ;;=99202^^54^613^2
 ;;^UTILITY(U,$J,358.3,11454,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11454,1,1,0)
 ;;=1^Expanded Problem Focus
 ;;^UTILITY(U,$J,358.3,11454,1,2,0)
 ;;=2^99202
 ;;^UTILITY(U,$J,358.3,11455,0)
 ;;=99203^^54^613^3
 ;;^UTILITY(U,$J,358.3,11455,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11455,1,1,0)
 ;;=1^Detailed
 ;;^UTILITY(U,$J,358.3,11455,1,2,0)
 ;;=2^99203
 ;;^UTILITY(U,$J,358.3,11456,0)
 ;;=99204^^54^613^4
 ;;^UTILITY(U,$J,358.3,11456,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11456,1,1,0)
 ;;=1^Comprehensive, Moderate
 ;;^UTILITY(U,$J,358.3,11456,1,2,0)
 ;;=2^99204
 ;;^UTILITY(U,$J,358.3,11457,0)
 ;;=99205^^54^613^5
 ;;^UTILITY(U,$J,358.3,11457,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11457,1,1,0)
 ;;=1^Comprehensive, High
 ;;^UTILITY(U,$J,358.3,11457,1,2,0)
 ;;=2^99205
 ;;^UTILITY(U,$J,358.3,11458,0)
 ;;=99211^^54^614^1
